| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), SCYX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.36M | - | - | |
| Other | 574.5K | - | - | |
| CFO | 398.5K | - | - | |
| Dir | 12.6K | - | - | |
| Dir | 12.1K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | Hanham Ann | Director | Buy | 3,200 | $6.25 | $20,000.00 | +758.3% | |
| Dec 21, 2020 | MacDonald Guy | Director | Buy | 8,000 | $6.25 | $50,000.00 | +200.0% | |
| Dec 21, 2020 | Sukenick Scott | General Counsel | Buy | 1,600 | $6.25 | $10,000.00 | +21.3% | |
| Dec 21, 2020 | Taglietti Marco | Chief Executive Officer | Buy | 40,000 | $6.25 | $250,000.00 | +57.4% | |
| Dec 12, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 166,667 | $0.90 | $150,000.30 | +31.6% | |
| Aug 21, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $1.11 | $11,100.00 | +1.9% | |
| Aug 15, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 10,015 | $1.01 | $10,115.15 | +2.0% | |
| Apr 17, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.63 | $40,750.00 | +5.2% | |
| Jan 10, 2019 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $0.69 | $17,250.00 | +5.5% | |
| Dec 31, 2018 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $0.46 | $11,500.00 | +5.8% |